An open-label, two-period comparative study on pharmacokinetics and safety of a combined ethinylestradiol/gestodene transdermal contraceptive patch
C Zhang, H Li, X **ong, S Zhai, Y Wei… - Drug Design …, 2017 - Taylor & Francis
We investigated the pharmacokinetics and safety profiles of a newly developed combined
ethinylestradiol (EE)/gestodene (GSD) transdermal contraceptive patch after a single-dose …
ethinylestradiol (EE)/gestodene (GSD) transdermal contraceptive patch after a single-dose …
[PDF][PDF] The risk of escape ovulation under treatment with low-dose combined oral contraceptives
K Elomaa - 2001 - core.ac.uk
The initial prerequisite for development of combined oral contraceptives (OCs) was created
far back in the 1930s, when the cybernetic mechanism of regulation between the …
far back in the 1930s, when the cybernetic mechanism of regulation between the …